Metraipolis › archive › dc_0860fea3bcf2
Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer — Europe PMC PMID:41912484
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41912484
- DOI
- 10.1038/s41419-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T16:40:55.910Z
- SHA-256 of the archived text
8da187360b679722a1c3f31d9876bb1481752d837f3a744b306ed2445025b1c8- Stable URL of this page
https://metraipolis.com/documento/dc_0860fea3bcf2
How to cite
Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer — Europe PMC PMID:41912484 — Europe PMC (en), https://europepmc.org/article/MED/41912484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0860fea3bcf2 (Metraipolis archive dc_0860fea3bcf2, sha256 8da187360b679722a1c3f31d9876bb1481752d837f3a744b306ed2445025b1c8)
BibTeX
@misc{dc0860fea3bcf2,
title = {Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer — Europe PMC PMID:41912484},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41912484},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0860fea3bcf2; sha256 8da187360b679722a1c3f31d9876bb1481752d837f3a744b306ed2445025b1c8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41912484. Agents can read the archived copy with the MCP tool read_document.